Evidence mapPaperPMID 40375306Full record

ArticleCardio-oncology (London, England)2025

Development and validation of an early prediction model for cardiac death risk in patients with light chain amyloidosis: a multicenter study.

Naidong Pang, Ying Tian, Hongjie Chi, Xiaohong Fu, Xin Li, Shuyu Wang, Feifei Pan, Dongying Wang, Lin Xu, Jingyi Luo and 2 more

Abstract read
In one paragraph

Article in Cardio-oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naidong PangDepartment of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-6843-9867
Ying TianDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Hongjie ChiDepartment of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Xiaohong FuDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xin LiDepartment of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Shuyu WangThe Third Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.
Feifei PanDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Dongying WangDepartment of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Lin XuDepartment of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Jingyi LuoDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Aijun LiuDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. laj0628@163.com.
XingPeng LiuDepartment of Cardiology, Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. xpliu71@vip.sina.com.

Funding

National Natural Science Foundation of China 82270325
6 · The paper itself

Abstract

backgroundCardiac involvement is the primary driver of death in systemic light chain (AL) amyloidosis. However, the early prediction of cardiac death risk in AL amyloidosis remains insufficient.

objectivesWe aimed to develop a novel prediction model and prognostic scoring system that enables early identification of these high-risk individuals.

methodsThis study enrolled 235 patients with confirmed AL cardiac amyloidosis from three hospitals. Patients from the first hospital were randomly assigned to the training and internal validation sets in an 8:2 ratio, while the external validation set comprised patients from the other two hospitals. Participants were categorized into a cardiac death group and a non-cardiac death group (including survivors and those who died from other causes). Five different machine learning models were used to train model, and model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.

resultsAll five models showed excellent performance on the training and internal validation sets. In external validation, both the Logistic Regression (LR) and Random Forest models achieved an area under the ROC curve of 0.873 and 0.877, respectively, and exhibited superior calibration and decision curve analysis. Considering the comprehensive performance and clinical applicability, the LR model was selected as the final prediction model. The visualization results are ultimately presented in a nomogram. Further analyses were performed on the newly identified predictors.

conclusionsThis prediction model enables early identification and risk assessment of cardiac death in patients with AL amyloidosis, exhibiting considerable predictive ability.

Indexed as

Cardiac deathLight chain amyloidosisMachine learningNomogramPrediction modelSudden cardiac death

Identifiers

PMID40375306
PMCPMC12079809

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.